Danaher Corp at JPMorgan Healthcare Conference Transcript
All right. Great. Thank you, everybody, for joining me today. I'm Casey Woodring from live science tools and diagnostics team. Welcome to our J.P. Morgan Healthcare Conference.
Pleased to be joined by Danaher's CEO, Rainer Blair. Rainer is going to go through the corporate presentation for Danaher, and then we'll do a Q&A session afterwards. Rainer, all you.
Thank you, Casey, and thanks to J.P. Morgan for having us this morning, and good day to everybody here in San Francisco as well as those of you who are here on the webcast. So before I jump in, please have a look at our forward-looking statements advisory as well as our GAAP reconciliation here, take the time to peruse those at another time.
And so let's get started. And before I do so, let me quickly outline what I'd like to talk about today. You probably saw our press release in the sense that we anticipate fourth quarter 2025 results to be ahead of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
